SYNOPSIS There is a significant fall in the serum folic acid level during pregnancy, reaching its lowest level at term. This is most pronounced in twin pregnancies. A similar but less spectacular fall occurs in the vitamin B12 concentration.
One of the main manifestations of both vitamin B12 and folic acid deficiency is megaloblastic anaemia. Osler (1919) was the first to describe megaloblastic anaemia in pregnancy, and until recently the disease was considered uncommon. During the last nine years, however, there have been several reports which suggest that megaloblastic anaemia is a frequent complication of late pregnancy responding promptly to the administration of folic acid (Scott, 1954; Cowan, 1957; Forshaw, Jones, Chisholm, and McGinley, 1957; Giles and Shuttleworth, 1958; Ainley, 1961) . Chanarin, MacGibbon, O'Sullivan, and Mollin (1959) , using folic-acid clearance and absorption tests, showed that folic acid depletion in pregnancy is by no means confined to patients with megaloblastic anaemia, for abnormally rapid folic acid clearance was obtained even in women without anaemia, especially in cases of twin pregnancy. On the other hand, women who receive folic acid as routine prophylaxis in late pregnancy have significantly higher haemoglobin levels at term than comparable controls (Giles and Burton, 1960; Dawson, More, and Aird, 1962 (Heinrich, 1954; Spray and Witts, 1958; Dawson, 1962; Baker, Jacob, Rajan, Swaminathan, 1962) . In this hospital, estimation of the serum vitamin B12 concentration has been a routine procedure in the investigation of anaemia of pregnancy since 1960. Folic-acid clearance tests (Chanarin et al., 1959) were introduced about the same time, but for various serum levels in pregnancy remained separate investigations and, as they were begun at different times, they do not necessarily cover the same case material. For this reason the results of the two vitamin assays have been recorded separately, and the analysis of the data differs in the two sections.
HAEMATOLOGICAL CLASSIFICATION OF MEGALOBLASTIC ANAEMIA
In Addisonian and other types of megaloblastic anaemia the bone marrow contains not only classical megaloblasts but also cells which in size and in texture of nuclear chromatin occupy an intermediate position between classical megaloblasts and normoblasts (Dacie and White, 1949) . Israels (1951) named these cells 'transitional megaloblasts' and associated their presence with less severe forms of megaloblastic anaemia. Experience in this and other centres has shown that this concept also applies to megaloblastic anaemia in pregnancy (Giles, 1960; Dawson, 1962 Double-strength medium was prepared as described by Jukes (1955) , the stock solutions being kept no longer than recommended by Barton-Wright (1961 Standards A 04 mg. per ml. solution of pteroylglutamic acid (Halewood Chemicals Ltd. or Lederle) was prepared as described by Jukes (1955) and stored frozen. On the day of the test it was diluted in water to give final concentrations ranging from 0 003 to 0-4 mug. per ml.
Procedure Sera were diluted 1 in lOin M/10 phosphate buffer (pH 6-1) containing 100 mg. ascorbic acid in each 100 ml., and autoclaved at 15 lb./sq. in. for two and a half minutes to precipitate protein. The supernatant was further diluted 1 in 5 to give a final concentration of 1 in 100 after the addition of an equal volume of doublestrength medium. The final volume in each 5 x I in. tube was 10 ml. The tubes were covered by Oxoid caps, autoclaved at 10 lb./sq. in. for 10 minutes, inoculated and incubated at 37°C. in a water bath. Growth was measured in an E.E.L. nephelometer after about 20 hours' incubation, the exact time varying with the rapidity of growth.
ESTIMATION OF LABILE FOLIC ACID The specimen of serum stored without ascorbic acid was autoclaved in buffer containing no ascorbic acid to destroy labile folic acid. The residual stable folic acid was then assayed by the method described above, using a final dilution of 1 in 50. Ascorbic acid was added to the medium. Total and stable folic acids were always measured in the same assay to ensure identical conditions. The labile folic acid level was obtained by subtracting the stable from the total folic acid value.
All glassware was washed in Brylyanz. tap water, and de-ionized water and stored, for not longer than two weeks, in ultra-violet light.
RESULTS OF FOLIC ACID DETERMINATIONS
SERUM FOLIC ACID IN NORMAL SUBJECTS In 58 normal subjects the serum folic acid ranged from 3-4 to 11-6 m,tg. per ml., with a mean of 6-57 m,ug. per ml.
The mean was somewhat higher in females than in males (Table III) but the difference was not statistically significant. The distribution in female subjects is shown in Figure 1 .
SERUM FOLIC ACID IN NORMOBLASTIC PREGNANT
WOMEN After excluding cases of twin pregnancy and of megaloblastic anaemia, serum folic acid levels of 162 pregnant women were available for analysis. The levels ranged from 1-6 to 7-2 m,ug. per ml., with a mean of 3-64 m,ug. per ml. (Table III) . This is significantly lower than the mean in non-pregnant 3-4-1 1-i6 6-57 3-7-10-0 6-13 3-4-11 6 6-90 (Fig. 2 ).
There was a significant, progressive folic. acid level during pregnancy, from per ml. in the third month to 3-04 m,ug. term (Fig. 2) . The monthly mean values significant deviation from a linear regr but when this line was extrapolated b beginning of pregnancy, the mean for nc women deviated significantly from it. degree polynomial (a parabola) fitted all without significant deviation and is Figure 2 .
The relevance of this statistical patt folic acid levels in individual women was by the examination of serial blood sampli woman throughout pregnancy. The level progressive fall to full term, similar to tha above (Fig. 3.) The patients who formed the basis of this investigation were not a random sample of the general population of pregnant women, but they showed no significant departure from a single population when their serum folic acid levels were grouped according to the source from which the patients were derived, those from general practitioners being subdivided into anaemic and non-anaemic (Table IV) . It was concluded that, in this series, neither of these factors had any influence on the serum folic acid level. Since the anaemia was almost invariably associated with iron deficiency, it may be inferred that iron 8 9 10 deficiency was also without influence. anaemia, diagnosed between the thirty-first week of pregnancy and 11 weeks after delivery, the range of Dverlapping serum folic acid levels was 0-3 to 4 0 m,tg. per ml.
( Table III) . Excluding two women with twin pregfall in the nancies (folic acid levels 1 1 and 2-0 m,ug. per ml.), 5 00 mHtg. the mean of the remaining 47 was 1-89 m,tg. per ml. per ml. at This is significantly lower than the mean value showed no during the last trimester of normal pregnancy. ession line, In 38 cases it was possible to group the serum sack to the folic acid levels according to the marrow picture, and n-pregnant the results of this analysis are shown in Table III (Tables III and V) . This is significantly lower than the expected mean of 3-37 m,ug. per ml., calculated from the levels in normal pregnant women at the same stages of gestation (Fig. 2) , and the range overlaps that found in megaloblastic anaemia. Range (mug./ml.) RESULTS In nine normal subjects the labile factor level ranged from 3-3 to 4-5 m,ug. per ml. (mean 4-0 mug. per ml.). In 35 normal women during the last three months of pregnancy the range was from 0-6 to 5-0 m,tg. per ml. (mean 2-72 m,ug. per ml.), whilst in 13 patients with megaloblastic anaemia the labile factor levels ranged from 0-3 to 0-9 m,ug. per ml., with a mean of 0-62 m,ug. per ml., which is significantly lower than in normal pregnancy. The distribution of labile factor levels is illustrated in Fig. 4 The mean vitamin B12 concentration in all pregnant women was 248 ,u,ug. per ml. (S.E. 6 72) and that of the control group 356 ,tug. per ml. (S.E. 7 00). The difference is statistically significant (P < 0-001). The distribution of vitamin B12 levels in the two categories (Fig. 5) shows that 33 % of pregnant women had values below 200 ,u,tg. per ml. compared with only 17 % of controls.
Of the 320 pregnant women in this series, 61 had normal haemoglobin levels; the remainder presented with anaemia. The majority of the anaemic patients (159 cases) suffered from simple iron deficiency, sometimes complicated by urinary infection, whilst 100 patients had megaloblastic anaemia. The mean vitamin B12 concentration in the three groups is shown in Table VI . TION When vitamin B12 levels in the sera of normal or iron-deficient pregnant women were classified according to the stage of pregnancy at which specimens had been taken a slight but steady fall in the vitamin B12 concentration became apparent, reaching the lowest level at term, to be followed by a rapid rise during the first four weeks of the puerperium (Fig. 6 ).
OTHER FACTORS IN RELATION TO THE VITAMIN B12
CONCENTRATION A relationship could not be estab- lished between vitamin B12 serum levels and the haemoglobin concentration when the two values were compared in 233 pregnant women.
Likewise there was no evidence to suggest that the fall in vitamin B12 concentration during pregnancy was in any way related to iron deficiency. Of 209 cases in which both the serum iron and vitamin B12 had been determined, only 12 patients (5 7 %) showed a dual deficiency (Fig. 7) . This was not an unexpected finding since the mean vitamin B12 level of irondeficient pregnant women was virtually the same as that in normal pregnancy. More surprising perhaps was the lack of a significant degree of correlation between vitamin B12 and folic acid serum levels in 59 women during the latter half of pregnancy.
In 12 cases of twin pregnancy the vitamin B12 concentration did not differ significantly from that in other pregnant women. Finally, no significant fall in vitamin B12 levels could be demonstrated with advancing age of the patient, nor with an increasing number of previous pregnancies. VITAMIN B12 LEVELS IN MEGALOBLASTIC ANAEMIA The mean vitamin B12 concentration in 100 cases of megaloblastic anaemia of pregnancy was 216 ,t,ug.
per ml. (S.E. 11-17). This compares with the mean of 266 ,u,ug. per ml. for all other pregnancies (S.E. 7-69), a difference which is statistically significant (P < 0 01). Figure 8 shows the distribution of vitamin B12 levels plotted against those in other pregnancies and reflects the difference in the mean values.
When the mean vitamin B12 levels in cases of megaloblastic anaemia were classified according to the stage of gestation at which the disease was diagnosed, i.e., from the 25th week of pregnancy to the fourth week in the puerperium, quite a different pattern emerged from that observed in other pregnant women (Fig. 6) Subnormal vitamin B12 levels (below 150 ,tug. per ml.) were found in 306o% of patients with megaloblastic anaemias but in only 14-1 % of other pregnant women, a significant difference (P < 0-01). Five patients, all below the age of 40, who presented with megaloblastic anaemia had serum vitamin B12 concentrations below 100 ,utsg. per ml. In all these cases the vitamin B12 rose to normal levels after one to three weeks' administration of folic acid alone (Table VII) .
As in the case of folic acid, the mean vitamin B12 concentration was lowest in cases with a florid megaloblastic bone marrow (grade 3). In patients whose marrow was classified as grade 2 the vitamin B12 concentration was rather higher, and in the mildest cases (grade 1) the vitamin B12 level approached that of normal women during late pregnancy (Table VIII) .
DISCUSSION
The two studies reported in this paper have demonstrated that both the serum folic acid and (Chanarin et al., 1959; Girdwood and Delamore, 1961; Scott, 1962) and which is also reflected in the relatively high folic acid levels in the blood of the foetus (Baker, Ziffer, Pasher, and Sobotka, 1958; Solomons, Lee, Wasserman, and Malkin, 1962) .
The significance of the corresponding fall in the vitamin B12 concentration is open to conjecture. Baker et al. (1958) found that vitamin B12 levels in specimens of cord blood were higher than in the corresponding maternal blood samples. This suggests that the maternal stores of vitamin B12 undergo depletion along with those of folic acid. Although haemodilution may play a part in lowering vitamin levels towards the end of pregnancy, this is unlikely to be the whole explanation.
In patients with megaloblastic anaemia the serum levels of both vitamins are lower than in normal pregnancy. Moreover, the mean serum concentrations reflect the degree of megaloblastic change in the bone marrow and thus lend support to the concept that there are varying degrees of megaloblastic erythropoiesis characterized by the number and types of megaloblasts in the marrow (Giles, 1960; Dawson, 1962) . Some authorities have questioned the diagnostic significance of transitional megaloblasts (Witts, 1962; Pinkerton, 1962) . On the other hand, these cells occur in undoubted cases of Addisonian anaemia, in which they can be the predominant erythroblasts. The results of the vitamin assays recorded in this paper suggest that transitional megaloblasts merely indicate a milder degree of the disease process which culminates in florid megaloblastosis.
It is difficult to explain why subnormal vitamin B12 levels are commoner in megaloblastic anaemia than in normal pregnancy, for previous workers (Badenoch, Callender, Evans, Turnbull, and Witts, 1955; Metz, Lewis, Keeley, and Hart, 1960) have found no evidence of impaired absorption of vitamin B12 in this disease. A possible explanation was sug-. gested by Cox and his co-workers (1959) , who attributed the low vitamin B12 concentration to excessive utilization of this vitamin in an effort to compensate for the lack of folic acid. Only in five cases of the present series were the vitamin B12 levels low enough to raise a suspicion of Addisonian anaemia, and in all these patients the vitamin B12 level returned to normal on folic-acid therapy alone. Cox, Meynell, Gaddie, and Cooke (1959) At first sight it is not easy to understand why of two pregnant women with identical serum folic acid levels one may present with megaloblastic anaemia while the other has maintained normal erythropoiesis. In order to explain this observation one might assume the existence of an additional factor necessary for the production of megaloblastic changes in the bone marrow (Scott, 1962) . This might be a constitutional predisposition to the disease, which is suggested by the tendency for the same patient to develop megaloblastic anaemia in successive pregnancies and also by an apparently abnormal blood group distribution (Giles, 1960; Ainley, 1961) .
There is, however, an alternative explanation which may be sought in the complexity of folic acid derivatives in the serum. If serum folic acid activity is assayed using Streptococcus faecalis as the test organism, or if the Lactobacillus casei assay is performed without prior addition of ascorbic acid, much lower values are obtained which do not in any way reflect the degree of folic acid depletion of the patient. These low values are merely a small stable fraction of the total serum folic acid. By adding ascorbic acid to the serum an additional labile factor can be preserved (Waters and Mollin, 1961) , and the total folic acid activity corresponds very much better with the degree of folic acid deficiency of the patient, as measured by different methods. It is, therefore, possible that the presence of variable amounts of stable factor may render the L. casei assay inaccurate. Since stable factor activity is usually low it is unlikely to affect the result where total folic acid activity is normal or high. With low total values, however, which are common in late pregnancy, the stable factor activity may materially affect the results and thus account for the overlap in serum levels between patients with megaloblastic anaemia and in normal women in late pregnancy.
By the simultaneous assay of total folic acid and stable factor activity in two samples of the same serum the labile folic acid was estimated in a series of 48 pregnant women, including 13 cases of megaloblastic anaemia. The results of this preliminary study are encouraging, for all patients with megaloblastic anaemia showed very low serum levels of labile factor and the overlap with other pregnancies has been virtually eliminated. If these findings can be confirmed in a larger series of cases it would appear that the serum assay of folic acid can now take its place as a practical laboratory test in the diagnosis of megaloblastic anaemia of pregnancy.
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